SBS2, which reflects the activity of the APOBEC family of cytidine deaminases, is known to drive mutation accumulation and elevate cancer risk.14 Moreover, SBS15 was significantly enriched in patients who achieved a PR (p = 0.038, Fig. 4e). This evidence concerns the gene CDA and cancer.